Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Monetary Freedom Guide: Plan Your Future - 2Understanding Various Sorts of Financial balances: An Extensive Outline
- 3A throat bone settles it - Nanotyrannus was not a juvenile T. rex
- 4Watch live as near-Earth asteroid Eros buzzes the Andromeda Galaxy on Nov. 30 (video)
- 56 Top Computer game Control center
- 5 Great Crossover Vehicles For Eco-friendliness In 2024
- Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too
- Which Diet Prompts the Incomparable Wellbeing Results?
- This Week In Space podcast: Episode 192 — Space, 2026!
- Uncover the Manageable Fish Practices: Sea agreeable Feasting
- Spots To Go Birdwatching All over the Planet
- Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
- Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- 2025 Arctic League telethon raises more than $39k
